Kotaro Sakamoto

1.5k total citations
56 papers, 1.2k citations indexed

About

Kotaro Sakamoto is a scholar working on Molecular Biology, Oncology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Kotaro Sakamoto has authored 56 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Molecular Biology, 16 papers in Oncology and 10 papers in Cellular and Molecular Neuroscience. Recurrent topics in Kotaro Sakamoto's work include Neuropeptides and Animal Physiology (10 papers), Receptor Mechanisms and Signaling (7 papers) and Protein Kinase Regulation and GTPase Signaling (6 papers). Kotaro Sakamoto is often cited by papers focused on Neuropeptides and Animal Physiology (10 papers), Receptor Mechanisms and Signaling (7 papers) and Protein Kinase Regulation and GTPase Signaling (6 papers). Kotaro Sakamoto collaborates with scholars based in Japan, United States and South Korea. Kotaro Sakamoto's co-authors include Yusuke Kamada, Masanobu Tsubaki, Tatsuki Itoh, Motohiro Imano, Shozo Nishida, Tomoya Takeda, Takao Satou, Hirotaka Shimaoka, Naoki Ogawa and Takatsugu Hirokawa and has published in prestigious journals such as Journal of Biological Chemistry, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Kotaro Sakamoto

55 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kotaro Sakamoto Japan 21 782 367 148 97 91 56 1.2k
Kenneth Dunner United States 14 866 1.1× 249 0.7× 95 0.6× 60 0.6× 177 1.9× 20 1.6k
Chad J. Miller United States 14 1.0k 1.3× 243 0.7× 118 0.8× 74 0.8× 113 1.2× 18 1.5k
Søren Østergaard Denmark 22 701 0.9× 220 0.6× 243 1.6× 198 2.0× 84 0.9× 49 1.3k
Julianne L. Holleran United States 18 1.0k 1.3× 356 1.0× 75 0.5× 38 0.4× 78 0.9× 55 1.4k
Zee-Fen Chang Taiwan 23 1.0k 1.3× 354 1.0× 170 1.1× 56 0.6× 135 1.5× 59 1.7k
Rob Ruijtenbeek Netherlands 21 854 1.1× 219 0.6× 90 0.6× 206 2.1× 151 1.7× 64 1.2k
Brian A. Joughin United States 23 1.2k 1.5× 357 1.0× 251 1.7× 57 0.6× 242 2.7× 40 1.7k
Dorothea Rutishauser Sweden 25 1.3k 1.6× 264 0.7× 151 1.0× 128 1.3× 221 2.4× 46 2.0k
Martin Eggert Germany 23 617 0.8× 136 0.4× 101 0.7× 131 1.4× 190 2.1× 41 1.2k

Countries citing papers authored by Kotaro Sakamoto

Since Specialization
Citations

This map shows the geographic impact of Kotaro Sakamoto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kotaro Sakamoto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kotaro Sakamoto more than expected).

Fields of papers citing papers by Kotaro Sakamoto

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kotaro Sakamoto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kotaro Sakamoto. The network helps show where Kotaro Sakamoto may publish in the future.

Co-authorship network of co-authors of Kotaro Sakamoto

This figure shows the co-authorship network connecting the top 25 collaborators of Kotaro Sakamoto. A scholar is included among the top collaborators of Kotaro Sakamoto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kotaro Sakamoto. Kotaro Sakamoto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Asano, S, Kotaro Sakamoto, Atsuko Hayata‐Takano, et al.. (2024). Blockade of vasoactive intestinal peptide receptor 2 (VIPR2) signaling suppresses cyclin D1-dependent cell-cycle progression in MCF-7 cells. Journal of Pharmacological Sciences. 154(3). 139–147. 3 indexed citations
3.
Sakamoto, Kotaro, et al.. (2023). Deep learning in random neural fields: Numerical experiments via neural tangent kernel. Neural Networks. 160. 148–163. 1 indexed citations
4.
Sakamoto, Kotaro, Wararat Kittikulsuth, Eijiro Miyako, et al.. (2023). The VIPR2-selective antagonist KS-133 changes macrophage polarization and exerts potent anti-tumor effects as a single agent and in combination with an anti-PD-1 antibody. PLoS ONE. 18(7). e0286651–e0286651. 6 indexed citations
5.
Sakamoto, Kotaro, Yun Qi, & Eijiro Miyako. (2023). Nanoformulation of the K-Ras(G12D)-inhibitory peptide KS-58 suppresses colorectal and pancreatic cancer-derived tumors. Scientific Reports. 13(1). 518–518. 10 indexed citations
6.
Sakamoto, Kotaro. (2022). Generation of KS-487 as a novel LRP1-binding cyclic peptide with higher affinity, higher stability and BBB permeability. Biochemistry and Biophysics Reports. 32. 101367–101367. 12 indexed citations
7.
Sakamoto, Kotaro, S Asano, Yukio Ago, & Takatsugu Hirokawa. (2022). AlphaFold version 2.0 elucidates the binding mechanism between VIPR2 and KS-133, and reveals an S–S bond (Cys25−Cys192) formation of functional significance for VIPR2. Biochemical and Biophysical Research Communications. 636(Pt 1). 10–16. 5 indexed citations
8.
Sakamoto, Kotaro, et al.. (2022). The K-Ras(G12D)-inhibitory peptide KS-58 suppresses growth of murine CT26 colorectal cancer cell-derived tumors. Scientific Reports. 12(1). 8121–8121. 16 indexed citations
9.
Sakamoto, Kotaro, et al.. (2021). A selective delta opioid receptor agonist SNC80, but not KNT-127, induced tremor-like behaviors via hippocampal glutamatergic system in mice. Brain Research. 1757. 147297–147297. 8 indexed citations
10.
Yasui, Takeshi, Takeshi Yamamoto, Nozomu Sakai, et al.. (2017). Discovery of a novel B-cell lymphoma 6 (BCL6)–corepressor interaction inhibitor by utilizing structure-based drug design. Bioorganic & Medicinal Chemistry. 25(17). 4876–4886. 21 indexed citations
11.
Adachi, Yusuke, et al.. (2017). Investigation on cellular uptake and pharmacodynamics of DOCK2-inhibitory peptides conjugated with cell-penetrating peptides. Bioorganic & Medicinal Chemistry. 25(7). 2148–2155. 8 indexed citations
12.
Sakamoto, Kotaro, Yoshihiro Ishibashi, Ryutaro Adachi, et al.. (2017). Identification of cytidine-5-triphosphate synthase1-selective inhibitory peptide from random peptide library displayed on T7 phage. Peptides. 94. 56–63. 6 indexed citations
13.
Sakamoto, Kotaro, Tokuyuki Shinohara, Yusuke Adachi, Taiji Asami, & Tetsuya Ohtaki. (2017). A novel LRP1-binding peptide L57 that crosses the blood brain barrier. Biochemistry and Biophysics Reports. 12. 135–139. 47 indexed citations
14.
Masuda, Yasushi, Satoshi Kumano, Jiro Noguchi, et al.. (2017). PEGylated neuromedin U-8 shows long-lasting anorectic activity and anti-obesity effect in mice by peripheral administration. Peptides. 94. 99–105. 9 indexed citations
15.
Sakamoto, Kotaro, Satoshi Sogabe, Yusuke Kamada, et al.. (2016). Discovery of high-affinity BCL6-binding peptide and its structure-activity relationship. Biochemical and Biophysical Research Communications. 482(2). 310–316. 26 indexed citations
16.
Sakamoto, Kotaro, Yusuke Adachi, Yusaku Komoike, et al.. (2016). Novel DOCK2-selective inhibitory peptide that suppresses B-cell line migration. Biochemical and Biophysical Research Communications. 483(1). 183–190. 20 indexed citations
17.
Tsubaki, Masanobu, Tomoya Takeda, Kotaro Sakamoto, et al.. (2015). Bisphosphonates and statins inhibit expression and secretion of MIP-1α via suppression of Ras/MEK/ERK/AML-1A and Ras/PI3K/Akt/AML-1A pathways.. PubMed. 5(1). 168–79. 14 indexed citations
18.
Tsubaki, Masanobu, Tomoya Takeda, Naoki Ogawa, et al.. (2015). Overexpression of survivin via activation of ERK1/2, Akt, and NF-κB plays a central role in vincristine resistance in multiple myeloma cells. Leukemia Research. 39(4). 445–452. 50 indexed citations
19.
Tsubaki, Masanobu, Tatsuki Itoh, Motohiro Imano, et al.. (2014). Nitrogen-containing bisphosphonates inhibit RANKL- and M-CSF-induced osteoclast formation through the inhibition of ERK1/2 and Akt activation. Journal of Biomedical Science. 21(1). 10–10. 58 indexed citations
20.
Ochs, HD, et al.. (1983). X-linked lymphoproliferative syndrome: abnormal antibody responses to bacteriophage phi X 174.. PubMed. 19(3). 321–3. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Kenneth Dunner Breakdown of academic impact, for papers by Chad J. Miller Breakdown of academic impact, for papers by Søren Østergaard Breakdown of academic impact, for papers by Julianne L. Holleran Breakdown of academic impact, for papers by Zee-Fen Chang Breakdown of academic impact, for papers by Rob Ruijtenbeek Breakdown of academic impact, for papers by Brian A. Joughin Breakdown of academic impact, for papers by Dorothea Rutishauser Breakdown of academic impact, for papers by Martin Eggert
Rankless by CCL
2026